Adjuvant therapy in improving the effectiveness of complex treatment of tuberculosis patients in modern conditions

One of the most important problems in phthisiology remains low indicators of the effectiveness of treatment of tuberculosis patients, especially with drug-resistant MBT. This article presents a review of the possibilities of adjuvant therapy in improving the effectiveness of complex anti-tuberculosis treatment. Adjuvant treatment is prescribed in addition to the anti-tuberculosis chemotherapy and is necessary in the work of a phthisiologist. More than one hundred studies were analyzed, proving that the use of the adjuvant Glutamyl-Cysteinyl-Glycinum dinatrium (Glutoxim) in the complex treatment of tuberculosis is safe and effective.